Publications

The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy.

Authors: MK Lehtinen, CS Bjornsson, SM Dymecki, RJ Gilbertson, DM Holtzman, ES Monuk...

Research group: Gilbertson Group

E-pub date: 6 Nov 2013

Journal name: J Neurosci

New kids on the block: group 2 innate lymphoid cells and type 2 inflammation in the lung.

Authors: TYF Halim, ANJ McKenzie

Research group: Halim Group

E-pub date: 1 Nov 2013

Journal name: Chest

Dissecting cancer heterogeneity–an unsupervised classification approach.

Authors: X Wang, F Markowetz, F De Sousa E Melo, JP Medema, L Vermeulen

Research group: Markowetz Group

E-pub date: 1 Nov 2013

Journal name: Int J Biochem Cell Biol

Approaches for assessing and discovering protein interactions in cancer.

Authors: H Mohammed, JS Carroll

Research group: Carroll Group

E-pub date: 1 Nov 2013

Journal name: Mol Cancer Res

EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib–Letter.

Authors: PJ Voon, DWY Tsui, N Rosenfeld, TM Chin

Research group:

E-pub date: 1 Nov 2013

Journal name: Mol Cancer Ther

Collaboration of AMPK and PKC to induce phosphorylation of Ser413 on PIP5K1B resulting in decreased kinase activity and reduced PtdIns(4,5)P2 synthesis in response to oxidative stress and energy restriction.

Authors: I van den Bout, DR Jones, ZH Shah, JR Halstead, W-J Keune, S Mohammed, CS D...

Research group: Proteomics

E-pub date: 1 Nov 2013

Journal name: Biochem J

Abstract PL05-03: Phylogenetic quantification of intra-tumor heterogeneity predicts time to relapse in high-grade serous ovarian cancer.

Authors: FM Markowetz

Research group: Markowetz Group

E-pub date: 1 Nov 2013

Journal name: Molecular Cancer Therapeutics

Abstract A234: In vivo RNAi screening to identify major players in pancreatic tumor maintenance and growth.

Authors: S Fenoglio, Y Soto-Feliciano, G Hannon, M Hemann

Research group: Hannon Group

E-pub date: 1 Nov 2013

Journal name: Molecular Cancer Therapeutics

Filters

Research Groups

Core Facilities

Start date

End date

The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy.

New kids on the block: group 2 innate lymphoid cells and type 2 inflammation in the lung.

Dissecting cancer heterogeneity–an unsupervised classification approach.

Approaches for assessing and discovering protein interactions in cancer.

EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib–Letter.

Collaboration of AMPK and PKC to induce phosphorylation of Ser413 on PIP5K1B resulting in decreased kinase activity and reduced PtdIns(4,5)P2 synthesis in response to oxidative stress and energy restriction.

Abstract PL05-03: Phylogenetic quantification of intra-tumor heterogeneity predicts time to relapse in high-grade serous ovarian cancer.

Abstract A234: In vivo RNAi screening to identify major players in pancreatic tumor maintenance and growth.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy.

New kids on the block: group 2 innate lymphoid cells and type 2 inflammation in the lung.

Dissecting cancer heterogeneity–an unsupervised classification approach.

Approaches for assessing and discovering protein interactions in cancer.

EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib–Letter.

Collaboration of AMPK and PKC to induce phosphorylation of Ser413 on PIP5K1B resulting in decreased kinase activity and reduced PtdIns(4,5)P2 synthesis in response to oxidative stress and energy restriction.

Abstract PL05-03: Phylogenetic quantification of intra-tumor heterogeneity predicts time to relapse in high-grade serous ovarian cancer.

Abstract A234: In vivo RNAi screening to identify major players in pancreatic tumor maintenance and growth.